Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-18-001166
Filing Date
2018-02-01
Accepted
2018-02-01 17:27:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b50118_actinium.htm 424B5 1172136
2 GRAPHIC image001.jpg GRAPHIC 28604
  Complete submission text file 0001213900-18-001166.txt   1212732
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-216748 | Film No.: 18567823
SIC: 2834 Pharmaceutical Preparations